InsiderTrades.com logo

GYRE Insider Trading

Insider Ownership Percentage: 10.00%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $157,123.68

Gyre Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Gyre Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Gyre Therapeutics Share Price & Price History

Current Price: $8.40
Price Change: ▲ Price Increase of +0.25 (3.07%)
As of 02/24/2026 05:00 PM ET

This chart shows the closing price history over time for GYRE up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Gyre Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/23/2025Songjiang MaPresidentSell182$10.24$1,863.682,808,642View SEC Filing Icon  
5/22/2025Songjiang MaPresidentSell2,000$10.97$21,940.002,808,824View SEC Filing Icon  
3/19/2025Songjiang MaPresidentSell2,000$10.13$20,260.002,827,018View SEC Filing Icon  
3/17/2025Songjiang MaPresidentSell2,000$12.09$24,180.002,829,260View SEC Filing Icon  
3/14/2025Songjiang MaPresidentSell2,000$12.31$24,620.002,831,260View SEC Filing Icon  
3/12/2025Songjiang MaPresidentSell2,000$11.74$23,480.002,835,260View SEC Filing Icon  
3/10/2025Songjiang MaPresidentSell2,000$10.14$20,280.002,839,260View SEC Filing Icon  
3/7/2025Songjiang MaPresidentSell2,000$10.25$20,500.002,841,260View SEC Filing Icon  
2/10/2025Songjiang MaPresidentSell2,000$11.90$23,800.002,877,138View SEC Filing Icon  
2/4/2025Songjiang MaPresidentSell2,000$11.62$23,240.002,885,138View SEC Filing Icon  
1/29/2025Songjiang MaPresidentSell2,000$11.43$22,860.002,893,138View SEC Filing Icon  
1/27/2025Songjiang MaPresidentSell2,000$11.18$22,360.002,897,138View SEC Filing Icon  
1/23/2025Songjiang MaPresidentSell2,000$10.49$20,980.002,901,138View SEC Filing Icon  
1/21/2025Songjiang MaPresidentSell2,000$10.85$21,700.002,905,138View SEC Filing Icon  
1/17/2025Songjiang MaPresidentSell2,000$10.72$21,440.002,907,138View SEC Filing Icon  
1/15/2025Songjiang MaPresidentSell2,000$10.85$21,700.002,911,138View SEC Filing Icon  
1/13/2025Songjiang MaPresidentSell56$10.10$565.602,915,138View SEC Filing Icon  
1/10/2025Songjiang MaPresidentSell1,057$10.02$10,591.142,915,194View SEC Filing Icon  
1/6/2025Songjiang MaPresidentSell941$10.16$9,560.562,917,526View SEC Filing Icon  
1/2/2025Songjiang MaPresidentSell2,000$12.40$24,800.002,920,467View SEC Filing Icon  
12/30/2024Songjiang MaPresidentSell2,000$12.50$25,000.002,924,467View SEC Filing Icon  
12/26/2024Songjiang MaPresidentSell2,000$12.70$25,400.002,928,467View SEC Filing Icon  
12/23/2024Songjiang MaPresidentSell2,000$12.27$24,540.002,932,467View SEC Filing Icon  
12/19/2024Songjiang MaPresidentSell2,000$10.82$21,640.002,936,467View SEC Filing Icon  
12/17/2024Songjiang MaPresidentSell2,000$11.05$22,100.002,940,467View SEC Filing Icon  
6/28/2024Nassim UsmanDirectorSell3,452$12.00$41,424.001,636View SEC Filing Icon  
5/1/2024Nassim UsmanDirectorSell20,000$14.13$282,600.001,636View SEC Filing Icon  
1/3/2024Songjiang MaPresidentSell833$11.85$9,871.052,918,467View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Gyre Therapeutics (NASDAQ:GYRE)

23.99% of Gyre Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at GYRE by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Gyre Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/17/2026State of Wisconsin Investment Board24,800$0.18M0.0%-36.4%0.026%Search for SEC Filing on Google Icon
2/16/2026Barclays PLC18,531$0.13M0.0%+38.3%0.019%Search for SEC Filing on Google Icon
2/13/2026Charles Schwab Investment Management Inc.169,158$1.19M0.0%+37.1%0.176%Search for SEC Filing on Google Icon
2/13/2026State Street Corp202,225$1.43M0.0%+10.7%0.210%Search for SEC Filing on Google Icon
2/13/2026Wells Fargo & Company MN12,919$91K0.0%+132.4%0.013%Search for SEC Filing on Google Icon
2/12/2026Dimensional Fund Advisors LP10,903$77K0.0%N/A0.011%Search for SEC Filing on Google Icon
2/10/2026Goldman Sachs Group Inc.31,108$0.22M0.0%+72.5%0.032%Search for SEC Filing on Google Icon
2/9/2026Geode Capital Management LLC423,222$2.99M0.0%+13.0%0.439%Search for SEC Filing on Google Icon
2/3/2026SBI Securities Co. Ltd.162,915$1.15M0.0%-2.9%0.169%Search for SEC Filing on Google Icon
1/1/2026JPMorgan Chase & Co.3,694$28K0.0%-42.8%0.004%Search for SEC Filing on Google Icon
11/17/2025Millennium Management LLC35,751$0.27M0.0%N/A0.037%Search for SEC Filing on Google Icon
11/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.4,203$31K0.0%-43.3%0.004%Search for SEC Filing on Google Icon
11/17/2025Alliancebernstein L.P.21,830$0.16M0.0%+9.5%0.023%Search for SEC Filing on Google Icon
11/14/2025Lazard Asset Management LLC14,932$0.11M0.0%N/A0.016%Search for SEC Filing on Google Icon
11/7/2025JPMorgan Chase & Co.3,694$28K0.0%-42.8%0.004%Search for SEC Filing on Google Icon
11/6/2025Rhumbline Advisers13,432$100K0.0%-17.0%0.014%Search for SEC Filing on Google Icon
11/5/2025SBI Securities Co. Ltd.167,866$1.25M0.0%-27.7%0.174%Search for SEC Filing on Google Icon
10/30/2025Strs Ohio21,100$0.16M0.0%+58.6%0.022%Search for SEC Filing on Google Icon
10/24/2025State of Alaska Department of Revenue5,219$38K0.0%N/A0.005%Search for SEC Filing on Google Icon
8/15/2025Bank of America Corp DE6,277$46K0.0%+28.8%0.007%Search for SEC Filing on Google Icon
8/14/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.7,413$54K0.0%+77.8%0.008%Search for SEC Filing on Google Icon
8/12/2025American Century Companies Inc.11,291$83K0.0%-52.6%0.012%Search for SEC Filing on Google Icon
8/12/2025JPMorgan Chase & Co.6,461$47K0.0%+84.6%0.007%Search for SEC Filing on Google Icon
8/8/2025Geode Capital Management LLC401,709$2.95M0.0%+28.6%0.428%Search for SEC Filing on Google Icon
8/8/2025SBI Securities Co. Ltd.232,299$1.71M0.0%+87.9%0.248%Search for SEC Filing on Google Icon
6/27/2025Goldman Sachs Group Inc.16,147$0.13M0.0%-38.8%0.017%Search for SEC Filing on Google Icon
5/16/2025Goldman Sachs Group Inc.16,147$0.13M0.0%-38.8%0.017%Search for SEC Filing on Google Icon
5/14/2025Advantage Alpha Capital Partners LP13,663$0.11M0.0%+54.0%0.015%Search for SEC Filing on Google Icon
5/13/2025American Century Companies Inc.23,825$0.18M0.0%N/A0.025%Search for SEC Filing on Google Icon
5/9/2025Charles Schwab Investment Management Inc.111,416$0.86M0.0%-2.7%0.119%Search for SEC Filing on Google Icon
5/2/2025SBI Securities Co. Ltd.123,629$0.95M0.0%+22.1%0.132%Search for SEC Filing on Google Icon
4/29/2025Bank of New York Mellon Corp16,492$0.13M0.0%+18.7%0.018%Search for SEC Filing on Google Icon
4/7/2025GAMMA Investing LLC1,822$0.14M0.0%+15,083.3%0.002%Search for SEC Filing on Google Icon
2/17/2025Bank of America Corp DE6,937$84K0.0%+40.4%0.007%Search for SEC Filing on Google Icon
2/14/2025Northern Trust Corp103,382$1.25M0.0%+9.1%0.111%Search for SEC Filing on Google Icon
2/13/2025Barclays PLC10,543$0.13M0.0%+13.5%0.011%Search for SEC Filing on Google Icon
2/13/2025Wells Fargo & Company MN4,016$49K0.0%+29.4%0.004%Search for SEC Filing on Google Icon
2/11/2025Advantage Alpha Capital Partners LP8,873$0.11M0.0%-66.7%0.009%Search for SEC Filing on Google Icon
2/6/2025Charles Schwab Investment Management Inc.114,566$1.39M0.0%+0.8%0.123%Search for SEC Filing on Google Icon
2/6/2025SBI Securities Co. Ltd.101,239$1.23M0.0%N/A0.108%Search for SEC Filing on Google Icon
2/4/2025Bank of New York Mellon Corp13,896$0.17M0.0%+11.1%0.015%Search for SEC Filing on Google Icon
11/19/2024Barclays PLC9,288$0.12M0.0%+281.8%0.010%Search for SEC Filing on Google Icon
11/16/2024Geode Capital Management LLC303,647$3.81M0.0%+16.9%0.325%Search for SEC Filing on Google Icon
11/15/2024Barclays PLC9,288$0.12M0.0%+281.8%0.010%Search for SEC Filing on Google Icon
11/15/2024State Street Corp104,490$1.31M0.0%+8.8%0.112%Search for SEC Filing on Google Icon
11/13/2024FMR LLC3,742$47K0.0%N/A0.004%Search for SEC Filing on Google Icon
11/13/2024Advantage Alpha Capital Partners LP26,634$0.33M0.1%N/A0.029%Search for SEC Filing on Google Icon
11/12/2024Charles Schwab Investment Management Inc.113,648$1.43M0.0%+392.2%0.122%Search for SEC Filing on Google Icon
8/14/2024Marshall Wace LLP10,720$0.13M0.0%-58.0%0.013%Search for SEC Filing on Google Icon
8/9/2024Renaissance Technologies LLC13,900$0.17M0.0%N/A0.016%Search for SEC Filing on Google Icon
8/9/2024WINTON GROUP Ltd18,467$0.22M0.0%N/A0.022%Search for SEC Filing on Google Icon
8/1/2024Rhumbline Advisers10,291$0.12M0.0%N/A0.012%Search for SEC Filing on Google Icon
7/26/2024Bank of New York Mellon Corp18,266$0.22M0.0%N/A0.021%Search for SEC Filing on Google Icon
5/10/2024Vanguard Group Inc.195,098$3.41M0.0%-1.5%0.228%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Gyre Therapeutics logo
Gyre Therapeutics, Inc., a biopharmaceutical company, primarily focuses on the development and commercialization of Hydronidone for the treatment of Metabolic Dysfunction Associated Steatohepatitis in the United States. Its Hydronidone is also being evaluated for the treatment of liver fibrosis across a spectrum of chronic liver diseases. In addition, it advances a product pipeline in China, including Pirfenidone, for dermatomyositis interstitial lung disease, systemic sclerosis-associated interstitial lung disease, and pneumoconiosis, as well as for diabetic kidney disease; and product candidates for acute-on-chronic liver failure, chronic obstructive pulmonary disease, and pulmonary arterial hypertension. The company was founded in 2002 and is headquartered in San Diego, California.
Read More on Gyre Therapeutics

Today's Range

Now: $8.40
Low: $8.27
High: $8.65

50 Day Range

MA: $7.69
Low: $6.81
High: $8.42

52 Week Range

Now: $8.40
Low: $6.11
High: $13.75

Volume

72,045 shs

Average Volume

71,726 shs

Market Capitalization

$809.20 million

P/E Ratio

280.09

Dividend Yield

N/A

Beta

1.97

Who are the company insiders with the largest holdings of Gyre Therapeutics?

Gyre Therapeutics' top insider investors include:
  1. Songjiang Ma (President)
  2. Nassim Usman (Director)
Learn More about top insider investors at Gyre Therapeutics.

Who are the major institutional investors of Gyre Therapeutics?

Gyre Therapeutics' top institutional shareholders include:
  1. Geode Capital Management LLC — 0.44%
  2. State Street Corp — 0.21%
  3. Charles Schwab Investment Management Inc. — 0.18%
  4. SBI Securities Co. Ltd. — 0.17%
  5. Goldman Sachs Group Inc. — 0.03%
  6. State of Wisconsin Investment Board — 0.03%
Learn More about top institutional investors of Gyre Therapeutics stock.

Which major investors are selling Gyre Therapeutics stock?

In the last quarter, GYRE stock was sold by these institutional investors:
  1. State of Wisconsin Investment Board
  2. SBI Securities Co. Ltd.

Which major investors are buying Gyre Therapeutics stock?

During the last quarter, GYRE stock was purchased by institutional investors including:
  1. Geode Capital Management LLC
  2. Charles Schwab Investment Management Inc.
  3. State Street Corp
  4. Goldman Sachs Group Inc.
  5. Dimensional Fund Advisors LP
  6. Jane Street Group LLC
  7. Wells Fargo & Company MN
  8. Barclays PLC